AVCR — Avricore Health Income Statement
0.000.00%
Last trade - 00:00- CA$5.57m
- CA$4.78m
- CA$3.49m
Annual income statement for Avricore Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.033 | 0.033 | 0.123 | 1.77 | 3.49 |
| Cost of Revenue | |||||
| Gross Profit | 0.015 | 0.017 | 0.031 | 0.457 | 1.2 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1.95 | 1.05 | 1.79 | 2.59 | 4.18 |
| Operating Profit | -1.91 | -1.02 | -1.67 | -0.818 | -0.693 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.92 | -1.17 | -1.71 | -0.818 | -0.701 |
| Net Income After Taxes | -1.92 | -1.17 | -1.71 | -0.818 | -0.701 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -2.11 | -1.17 | -1.71 | -0.818 | -0.701 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.11 | -1.17 | -1.71 | -0.818 | -0.701 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.034 | -0.017 | -0.019 | -0.008 | -0.007 |